Mar. 10 at 3:54 PM
The B2i Digital team is pleased to announce that Aethlon Medical, Inc. (Nasdaq:
$AEMD) is participating in the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, on Thursday, March 12, 2026, at 1:00 PM EDT. The session will be moderated by M. Marin, Senior Analyst at Zacks Small Cap Research.
The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/otc-life-sciences-virtual-investor-forum
Virtual Investor Conferences brings together public companies and a global audience of retail and institutional investors for live executive presentations, Q&A sessions, and on-demand replays. The platform is open to public companies listed on NYSE, Nasdaq, TSX, CSE, ASX, and the OTC Markets.
Aethlon Medical is a clinical-stage medical device company headquartered in San Diego, California, advancing the Hemopurifier to address unmet needs in oncology and infectious disease. The Hemopurifier is a novel platform designed to selectively remove circulating pathogenic targets from biologic fluids.
Presenting on behalf of Aethlon Medical will be Jim Frakes, Chief Executive Officer and Chief Financial Officer. Mr. Frakes joined Aethlon in 2008 and brings 27 years of CFO-level financial responsibility for publicly traded companies, with experience spanning IPOs, follow-on offerings, private placements, acquisitions, and public reporting. He holds an MBA from the University of Southern California and completed his BA with Honors at Stanford University.
To register for this presentation, visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5261181/aethlon-medical-nasdaq-aemd?utm_source=b2i&utm_medium=marketing&utm_campaign=0326LifeSciencesVIC
For more information about Aethlon Medical, visit: https://www.aethlonmedical.com/investors
Content about any specific company was provided and approved by that company or is available in the public domain. B2i Digital, Inc. has not independently verified the accuracy of the information contained herein. The content contained herein is informational only, and no content contained herein shall be considered an offer to solicit the sale of any security or make a recommendation to purchase a security. B2i Digital is not a broker-dealer or investment adviser.
